Devyser

Our CCO, Theis Kipling, will attend the 43rd Annual J.P. Morgan Healthcare Conference next week. Connect with him to learn more about how our NGS products streamline laboratory workflows and help improve patient outcomes. #JPM2025 Learn more about us at hubs.la/Q031RHQ70!

As the year ends, we want to express our gratitude to our customers, partners, and distributors. Your support, trust, and collaboration have made this year truly special. Thank you for being part of our journey. Here’s to new beginnings and continued success.

Devyser is heading to the #ASHI Annual Meeting in the US! Meet our team next week and learn about our post-transplant lab products and clinical services available in our US based CLIA-certified lab.  #ASHI2024

Join us at the ASHI 50th Annual Meeting! Our transplant products will be represented in 7 posters, featuring our research and innovations in dd-cfDNA monitoring for solid organ transplants. We're excited to share our latest advancements and answer your questions.

October is Breast Cancer Awareness Month! We're proud to support this important cause and raise awareness about the importance of early detection and genetic testing. Let's join hands to support the fight against breast cancer. 💖 #BreastCancerAwareness #Devyser

Today is Familial Hypercholesterolemia (FH) Awareness Day! 🌍 FH is a genetic condition that leads to high cholesterol levels from birth, putting millions at risk for early heart disease. Did you know? 🧬 FH is genetic: It’s an inherited condition that leads to high cholesterol levels from birth. 🏥 1 in 250 people worldwide have FH, but 90% remain undiagnosed. 👶 Children with FH can inherit the condition from just one affected parent. Early detection through genetic testing and treatment can help prevent heart disease and save lives. Let’s raise awareness and make early diagnosis a priority! #FHAwarenessDay #HeartHealth #GeneticTesting #PreventHeartDisease #FH #FHeurope

Streamlining FH Testing at Sahlgrenska University Hospital 🔬 Familial Hypercholesterolemia (FH) testing can be complex, but at Sahlgrenska University Hospital, genetic scientist Emma Samuelsson and her team are making it simpler and faster. By adopting Devyser FH, they’ve optimized their workflow with a one-tube solution that reduces errors and saves valuable time. "Devyser’s workflow is like a dream," says Emma. Learn how Devyser FH is reshaping FH testing for improved turnaround time and efficiency. 🔗 hubs.la/Q02QdByj0 #FHTesting #GeneticTesting #HealthcareInnovation #DevyserFH #LabEfficiency

Amplicon Suite - Now powered by AWS!☁️ We’re excited to announce that Amplicon Suite, our CE-IVD-marked software solution, is now available in the cloud hosted by AWS! Level up your NGS data analysis with the power of the cloud! hubs.la/Q02Q4j0_0 #CloudBased #NGS

Discover how NGS can improve cystic fibrosis testing! 🧬 Learn how Next-Generation Sequencing offers flexibility in identifying different mutations and provides effective whole gene analysis. 🔗 hubs.la/Q02Nh2Sw0 #CysticFibrosis #NGS #Genetics #HealthcareInnovation

Ability to address genetic diversity in cystic fibrosis testing is crucial.🌍 Our assays are designed to ensure equitable screening across multi-ethnic populations. Discover more in our detailed infographic. 🔗 hubs.la/Q02MRl3q0 #CysticFibrosis #GeneticTesting

🚨 Don't miss out! Join us for a webinar on the importance of genetic testing in Familial Hypercholesterolemia with Prof. Mafalda Bourbon. 🧬 In the webinar, you will learn: 👥 Prevalence and diagnosis of FH and how to improve. 🔍 How early detection can improve patient outcomes 🛡️ Insight into how 20% of patients with premature myocardial infarctions (MIs) have FH, and how these MIs can be preventable with early genetic testing. Save the date → Sept 24, 4pm SGT | 10am CET | 10am ET. Register now! 🔗hubs.la/Q02MGsvX0 #GeneticTesting #FH #Cardiology

Explore research on Thalassemia and learn how our next-generation genetic testing solutions are enhancing the understanding and diagnosis of this condition. As featured in top scientific journals 🔍. Find the papers here —> hubs.la/Q02LR-VQ0

Breaking News at Devyser! 🔥 We’ve just secured our new ISO and MDSAP certifications, officially giving the green light to our new Årsta site for manufacturing.🚀 Stay tuned because big things are on the horizon, and we can’t wait to share what’s next!

As demographics shift, genetic diversity becomes even more important in cystic fibrosis testing. 📊 See how our solutions adapt to these changes. Check out our infographic for more insights. 🔗 lnkd.in/dvt9UnkU #CysticFibrosis #Genetics #NGS #Healthcare

We are thrilled to announce that we have won our first Devyser Thalassemia tender in the Scandinavian market! 🎉 📷 Read the full press release devyser.com/blog/devyser-w… #Devyser #Thalassemia #NGS #ScandinavianMarket

Today, we are thrilled to announce that we are expanding our agreement with @thermofisher to exclusively distribute our post-transplantation products globally. 🌍 Stay tuned and follow Devyser for all the latest updates. 📢 Read the full press release investors.devyser.com/en/press/devys…

We're excited to be attending EFI 2024! Even more, we're proud to showcase 4 posters at the event. Visit us our booth just infront of our partner Thermo Fisher Scientific and don't forget to sign up below to get notified when the posters are available --> hubs.la/Q02wvWLf0

Today, 8th of May, is Thalassemia awareness day ♥️ We hope to spread awareness for this disease! Read here to find out more about Thalassemia —>hubs.ly/Q02wv7Bc0 #ITD2024 #BeAwareShareCare #TreatmentForThal and #TreatmentForAll #InternationalThalassaemiaDay

We're excited to announce that we will be part of the Swiss Society of Medical Genetics annual meeting in Bern next week! 🇨🇭 Join us at booth 6 to discuss and share insights on our IVDR single-tube diagnostic solutions for Hereditary Diseases.